See more : Rokk3r Inc. (ROKK) Income Statement Analysis – Financial Results
Complete financial analysis of BG Medicine, Inc. (BGMD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of BG Medicine, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- BAIC Motor Corporation Limited (1958.HK) Income Statement Analysis – Financial Results
- ULS Technology plc (ULS.L) Income Statement Analysis – Financial Results
- Veren Inc. (VRN) Income Statement Analysis – Financial Results
- Lion Travel Service Co., Ltd. (2731.TW) Income Statement Analysis – Financial Results
- NeuroOne Medical Technologies Corporation (NMTC) Income Statement Analysis – Financial Results
BG Medicine, Inc. (BGMD)
About BG Medicine, Inc.
BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
| Metric | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 1.57M | 2.79M | 4.07M | 2.82M | 1.63M | 819.00K | 8.49M | 14.58M | 6.05M | 1.53M | 2.52M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 505.00K | 956.00K | 1.39M | 957.00K | 619.00K | 786.00K | 8.43M | 13.82M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 1.06M | 1.83M | 2.68M | 1.86M | 1.02M | 33.00K | 59.00K | 758.00K | 6.05M | 1.53M | 2.52M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 67.75% | 65.70% | 65.90% | 66.00% | 62.12% | 4.03% | 0.69% | 5.20% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 1.77M | 2.39M | 3.74M | 7.58M | 8.00M | 6.54M | 8.53M | 6.86M | 7.83M | 7.13M | 8.66M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 3.62M | 4.51M | 7.13M | 7.55M | 0.00 | 0.00 | 0.00 | 0.00 | 2.41M | 2.41M | 2.57M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 302.00K | 2.29M | 6.19M | 9.45M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 3.92M | 6.80M | 13.32M | 17.00M | 10.50M | 8.10M | 7.52M | 4.48M | 2.41M | 2.41M | 2.57M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 5.69M | 9.19M | 17.06M | 17.00M | 18.50M | 14.64M | 16.05M | 11.33M | 10.24M | 9.24M | 11.06M |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 6.20M | 10.15M | 18.45M | 17.96M | 19.12M | 15.43M | 24.48M | 25.16M | 10.24M | 9.24M | 11.06M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.00K | 15.00K | 22.00K | 31.00K | 5.00K | 121.00K | 422.00K | 24.00K | 22.00K | 89.00K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 159.00K | 728.00K | 1.17M | 1.08M | 89.00K | 2.79M | 244.00K | 4.92M | 574.00K | 1.59M | 1.46M |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 87.00K | 131.00K | 165.00K | 273.00K | 420.00K | 540.00K | 753.00K | 593.00K | 655.00K | 1.05M | 1.71M |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -5.06M | -7.21M | -14.76M | -22.41M | -17.07M | -13.83M | -15.24M | -9.98M | -3.54M | -6.65M | -6.83M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -290.10% | -264.08% | -352.54% | -537.26% | -1,067.69% | -1,745.67% | -179.14% | -68.46% | -58.50% | -501.70% | -561.94% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -4.63M | -7.36M | -14.37M | -22.73M | -17.49M | -14.61M | -15.99M | -10.58M | -4.19M | -7.70M | -8.54M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -295.66% | -264.16% | -352.91% | -807.39% | -1,070.07% | -1,783.39% | -188.32% | -72.53% | -69.34% | -502.87% | -338.93% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -673.00K | -702.00K | -1.48M | -1.04M | -97.00K | 231.00K | -149.00K | -4.50M | 0.00 | 1.04M | 7.33M |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -5.30M | -8.06M | -15.85M | -23.77M | -17.52M | -14.38M | -16.01M | 0.00 | 0.00 | -6.67M | -1.21M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -338.63% | -289.34% | -389.12% | -844.37% | -1,072.46% | -1,755.19% | -188.62% | 0.00% | 0.00% | -435.31% | -47.98% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 159.00K | 597.00K | 1.00M | 810.00K | -323.00K | 2.56M | 149.00K | 4.50M | 550.00K | 528.00K | -5.96M |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -5.30M | -8.06M | -15.85M | -23.77M | -17.58M | -17.16M | -16.14M | -15.07M | -4.74M | -8.23M | -2.58M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -338.63% | -289.34% | -389.12% | -844.37% | -1,076.01% | -2,095.48% | -190.07% | -103.39% | -78.43% | -537.34% | -102.50% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.55 | -0.99 | -2.33 | -4.70 | -3.99 | -23.10 | -22.02 | -20.29 | -6.38 | -11.08 | -3.48 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.55 | -0.99 | -2.33 | -4.70 | -3.99 | -23.10 | -22.02 | -20.29 | -6.38 | -11.08 | -3.48 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 9.61M | 8.18M | 6.80M | 5.05M | 4.41M | 742.86K | 732.70K | 742.86K | 742.86K | 742.86K | 742.86K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 9.61M | 8.18M | 6.80M | 5.05M | 4.41M | 742.86K | 732.70K | 742.86K | 742.86K | 742.86K | 742.86K |
Source: https://incomestatements.info
Category: Stock Reports